Also known as: Midnight Star Kush

Midnight Star

A lesser-documented indica-leaning cultivar whose lineage and effects claims rest largely on breeder marketing rather than verifiable data.

Sourced and fact-checked
8 cited sources
Published 1 hour ago
How this page was made
↯ The honest take

Midnight Star is one of those strain names that shows up in seed bank catalogs and dispensary menus without a clear paper trail. There is no peer-reviewed chemistry, no verified breeder record, and multiple unrelated plants have been sold under this name. Anything you read about its 'deep body stone' or 'sedative indica effects' is anecdote and marketing, not science. If you like it, that's fine — just don't treat marketing copy as fact.

Overview

Midnight Star is a cannabis cultivar name that circulates on seed bank listings and dispensary menus, primarily in North America and parts of Europe. Unlike well-documented cultivars such as OG Kush or Chemdog, there is no widely accepted origin story, no consistent chemical profile in published literature, and no single breeder universally credited with the line. No data

That matters because 'strain' names in cannabis are not regulated trademarks in most jurisdictions. Two growers can sell genetically unrelated plants under the same name, and chemotype studies have repeatedly shown that samples sharing a strain name can differ substantially in cannabinoid and terpene content [1][2]. Midnight Star is a good example of a name that has outrun its documentation.

Chemistry

There are no peer-reviewed cannabinoid or terpene analyses of Midnight Star that we could locate. Vendor listings typically claim THC in the high teens to low twenties percent and negligible CBD, which is consistent with most modern drug-type cannabis on the legal market [3] but tells you nothing specific about this cultivar. No data

Some listings describe myrcene as the dominant terpene, often accompanied by the folkloric claim that myrcene above 0.5% guarantees a 'couch-lock' indica effect. That threshold is marketing folklore with no controlled human evidence behind it [4]. Disputed

If you want to know what is actually in a given batch of Midnight Star, the only reliable answer is the certificate of analysis (COA) from the specific producer. Do not extrapolate from one lab result to the strain as a whole.

Reported effects

Vendor and community descriptions of Midnight Star lean heavily on 'nighttime,' 'sedative,' 'relaxing body high,' and 'sleep aid' language. These are consumer reports, not clinical findings. Anecdote

There are no clinical trials of Midnight Star specifically — and to be clear, there are essentially no controlled clinical trials of any named cannabis cultivar for effects like sleep or relaxation. Trials use standardized extracts or whole-plant preparations with known THC:CBD ratios, not branded strains [5]. The persistent industry claim that 'indicas sedate and sativas energize' also does not survive scrutiny; the indica/sativa split does not reliably predict subjective effects [6]. Disputed

What's plausible: a high-THC flower consumed in the evening will produce sedation in many users, especially at higher doses. That is a THC dose effect, not a Midnight Star effect.

Lineage

Reported lineages for Midnight Star vary by seller. Some list it as a cross involving Northern Lights, others tie it to a Kush parent, and still others provide no parents at all. We could not locate a primary-source breeder record — a dated seed release, an interview, or a documented pheno hunt — that establishes a single canonical pedigree. No data

This is common in cannabis. Because clones and seeds travel informally, and because 'Midnight Star' is an evocative name that many breeders have independently used, it is likely that more than one unrelated plant carries the label. Genetic studies of the cannabis market have found frequent mismatches between strain names and underlying genotypes [1]. Strong evidence

Until someone publishes a verifiable pedigree with a genetic fingerprint, treat any Midnight Star lineage chart as unverified.

Cultivation basics

Because 'Midnight Star' does not refer to a single documented genetic line, generic cultivation advice is about all we can offer honestly. Vendors typically describe it as an indoor-friendly plant with an 8-9 week flowering window, moderate stretch, and dense flowers — a description that fits most modern indica-leaning hybrids [7]. Weak / limited

Standard practices apply: stable vegetative light cycles, careful humidity management in late flower to reduce botrytis risk, and calibrated nutrient feeding. If you obtain seeds or clones labeled Midnight Star, expect phenotypic variation between plants, especially from seed, and select for the expression you like rather than trusting the label to guarantee a specific outcome.

Marketing vs. reality

Marketing copy around Midnight Star typically promises: (1) a specific indica-dominant lineage, (2) a predictable sedative effect, (3) a myrcene-forward terpene profile, and (4) reliable THC in a narrow range. The reality is:

None of this means Midnight Star is a bad product. It means the name is not doing the work that marketers imply. Judge each batch by its COA and your own experience, not the strain name on the jar.

Sources

  1. Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1(1), 3.
  2. Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
  3. Peer-reviewed ElSohly, M. A., Chandra, S., Radwan, M., Majumdar, C. G., & Church, J. C. (2021). A comprehensive review of cannabis potency in the United States in the last decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6(6), 603-606.
  4. Peer-reviewed Ferber, S. G., Namdar, D., Hen-Shoval, D., et al. (2020). The 'entourage effect': terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. Current Neuropharmacology, 18(2), 87-96.
  5. Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
  6. Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44-46.
  7. Book Cervantes, J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.
  8. Reported Jikomes, N. (2023). Cannabis potency inflation is real, widespread, and getting worse. Leafly / Analytical 360 data reporting.

How this page was made

Generation history

Aug 29, 2026
Fact-check pass — raised 2 flags
Aug 29, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.